GCP
EVH icon

GSA Capital Partners’s Evolent Health EVH Stock Holding History

GSA Capital Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$713K Buy
312,659
+4,510
+1% +$14.3K 0.04% 687
2025
Q4 		$1.23M Buy
308,149
+291,173
+1,715% +$1.62M 0.11% 254
2025
Q3 		$144K Buy
+16,976
New +$165K 0.01% 1485
2025
Q1 		– Sell
-40,370
Closed -$454K – 1772
2024
Q4 		$454K Buy
+40,370
New +$709K 0.03% 965
2024
Q2 		– Sell
-6,654
Closed -$218K – 1737
2024
Q1 		$218K Buy
+6,654
New +$212K 0.02% 1373
2022
Q2 		– Sell
-16,873
Closed -$545K – 1505
2022
Q1 		$545K Buy
+16,873
New +$442K 0.07% 469
2021
Q1 		– Sell
-15,690
Closed -$252K – 1214
2020
Q4 		$252K Sell
15,690
-75,210
-83% -$994K 0.04% 840
2020
Q3 		$1.13M Buy
+90,900
New +$1.07M 0.19% 81
2020
Q2 		– Sell
-37,652
Closed -$204K – 746
2020
Q1 		$204K Buy
+37,652
New +$336K 0.05% 748
2019
Q3 		– Sell
-32,374
Closed -$257K – 1482
2019
Q2 		$257K Buy
+32,374
New +$383K 0.03% 1097
2017
Q2 		– Sell
-21,900
Closed -$488K – 1744
2017
Q1 		$488K Buy
+21,900
New +$420K 0.03% 1112

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSA Capital Partners's EVH Position: Q1 2026 in Review

GSA Capital Partners increased its Evolent Health (EVH) stake by 1.5% in Q1 2026, buying an estimated $14.3K and bringing the position to 312,659 shares worth $713K. The position accounts for 0.04% of the portfolio, ranked #687.

GSA Capital Partners first reported a position in EVH in Q1 2017 and has held it in 11 quarters since. The position peaked at $1.23M in Q4 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • GSA Capital Partners held 312,659 shares of Evolent Health worth $713K as of Q1 2026.
  • GSA Capital Partners bought 4,510 Evolent Health shares in Q1 2026, an estimated $14.3K.
  • Evolent Health made up 0.04% of GSA Capital Partners's portfolio in Q1 2026, its #687 holding.
  • GSA Capital Partners first reported a position in Evolent Health in Q1 2017 and has held it in 11 quarters since.
  • GSA Capital Partners's Evolent Health position peaked at $1.23M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.